Collectively, our findings suggest that OSEE exerts its anti-proliferative effects against BC by regulating several pathways, including those for STAT3, ROS, p38 MAP kinase, p21, and Ki67, satisfying the multi-target requirement of an effective anticancer therapeutic strategy, as already discussed. The gene discussed is MAPK14; the disease is breast cancer.